Publications & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:

Publications Presentations

Improvements in Disability, Migraine Frequency, and the Interictal Period with INP104: Results from the Phase 3 STOP 301 Study

Presented at the AAN Annual Meeting, April 2-7, 2022 Authors: Cynthia E. Armand, Dawn C. Buse, Robert Vann, Sutapa Ray, Stephen B. Shrewsbury, Sheena K. Aurora Objective: To report data from a post hoc analysis on headache-related disability and exploratory outcome measures relevant to interictal…

Exploratory Efficacy of INP104 by Migraine Attack Severity and Time of Dosing: Results From the Phase 3 STOP 301 Study

Presented at the AAN Annual Meeting, April 2-7, 2022 Authors: Brian D. Loftus, Michelle Murphy, Christopher J. Fitzpatrick, Sutapa Ray, Stephen B. Shrewsbury, Sheena K. Aurora Objective: This post hoc analysis investigated self-reported exploratory efficacy for INP104-treated migraine attacks (MAs) based on severity and time…

Exploratory Efficacy of INP104 in Migraine Patients By Prior Treatment

Presented at the AAN Annual Meeting, April 2-7, 2022 Authors: Tanya R. Bilchik, Robert Vann, Sutapa Ray, Stephen B. Shrewsbury, Sheena K. Aurora Objective: To report data from a post hoc analysis of the exploratory efficacy of INP104 treatment over 24 weeks based on…

1 2 3